Accord Doxorubicin Hydrochloride Injection is a 2 mg/mL solution supplied in a 25 mL vial for prescription use. It is a chemotherapy drug used to treat cancer and is indicated for intravenous and intravesical BP use under professional supervision. This product is DIN 02381982 and requires a prescription in Canada, including Quebec. Designed for controlled clinical settings, it supports oncology protocols as directed by a licensed healthcare professional.